VolvenixIsomorphic Labs vs Freenome
Independent comparison — features, pros, cons, pricing and rankings.
ChatGPT 
Claude 
Gemini 
Midjourney 
DALL-E 
Stable Diffusion 
Notion AI 
Canva 
Grammarly 
GitHub Copilot 
ElevenLabs 
Perplexity 
Runway 
Synthesia 
Fireflies.ai 
Hugging Face Hub 
| Dimension | Isomorphic Labs | Freenome |
|---|---|---|
| Accuracy & Reliability | — | |
| Ease of Use | — | |
| Features & Capability | — | |
| Value for Money | — | |
| Performance & Speed | — | |
| Popularity & Adoption | — |
Who each tool serves best — and when to pick the other one.
Research scientists and biotech teams focused on protein structure prediction and drug discovery.
- You need AI-based protein structure predictions to accelerate drug discovery projects.
- You want to integrate molecular modeling insights into precision medicine research.
- Your team requires cutting-edge AI tools specialized in biological sequence analysis.
Organizations without domain expertise in molecular biology or those needing broad SaaS integrations.
- You need a fully mature platform with extensive third-party integrations and APIs.
- Free-tier limits are a blocker for your large-scale or enterprise-level research needs.
- You require a tool with broad support for non-biological AI applications.
Accuracy and applicability of AI-driven protein structure predictions for research goals.
Healthcare professionals and researchers seeking advanced, non-invasive early cancer detection tools using multiomics data.
- You need non-invasive early cancer detection from blood samples with genomic insights.
- You want a precision medicine platform tailored for clinical genomics and oncology research.
- Your team requires AI-driven multiomics analysis for biomarker discovery and diagnostics.
Individuals or small teams needing transparent pricing or general-purpose genomic analysis tools without clinical focus.
- You need a fully transparent, self-service pricing model for small-scale use.
- Free-tier limits are a blocker for your research or clinical trial budget constraints.
- You require a broad genomic analysis platform beyond cancer diagnostics.
The platform’s ability to integrate multiomics data for early cancer detection is the primary deciding factor.
A canonical comparison across capabilities common to this category. Vendor-specific extras appear below in "Highlighted Features".
| Capability | Isomorphic Labs | Freenome |
|---|---|---|
|
Free Tier Available
Usable without payment (with usage limits)
|
✓ | ✓ |
Each tool's marketing-listed features. Where a feature appears under one tool but not the other, it usually reflects how the vendor describes their product — not a definitive capability gap.
- Protein Structure Prediction — Predicts 3D protein structures from sequences
- AI-Powered Molecular Modeling — Uses deep learning models for biological insights
- Cloud-based access — Accessible via web platform without local setup
- Precision Medicine Focus — Supports drug discovery and clinical genomics
- Integration Support — Limited or no public integration options
- Multiomics Analysis — Combines genomic and proteomic data for cancer detection
- Blood-based Testing — Non-invasive liquid biopsy approach
- Precision Medicine Platform — Supports personalized diagnostics and treatment planning
- Clinical Genomics Integration — Designed for clinical and research use
- AI Biomarker Discovery — Machine learning identifies relevant cancer biomarkers
- Leverages deep learning for accurate protein modeling
- Targets precision medicine and drug discovery
- Cloud-based platform for easy access
- Backed by expertise in AI and biology
- Supports research-driven workflows
- Combines genomic and proteomic data for enhanced detection accuracy
- Non-invasive testing improves patient comfort and compliance
- Focus on early-stage cancer enables timely intervention
- Strong clinical research foundation and partnerships
- AI-driven biomarker discovery supports precision medicine
- Limited public pricing and plan transparency
- No public API or integration options documented
- Not suited for users without molecular biology expertise
- Pricing details are not publicly disclosed
- Limited availability outside clinical and research settings
- No public API or developer integrations
- Drug discovery research
- Protein structure analysis
- Precision medicine development
- Biotech R&D workflows
- Molecular biology research
- Early-stage cancer screening
- Biomarker discovery for oncology research
- Non-invasive liquid biopsy diagnostics
- Precision medicine treatment planning
- Clinical trial patient stratification
Natural languages each tool generates and understands. Primary languages are listed first.
What each tool can accept (input) and produce (output) — text, image, audio, video, code.
Offers a freemium model with limited public details; pricing tiers and features are not fully disclosed.
-
Free
Free
Offers a freemium model with limited public details; primarily targets clinical and research customers with custom pricing.
-
Free
Free
Regulatory frameworks each tool claims compliance with (HIPAA, SOC 2, GDPR, etc.).
None listed.
Vendor-published numbers each tool highlights — usage scale, breadth, and operational stats. Different tools track different metrics, so direct row-by-row comparison usually isn't meaningful.
- Prediction Accuracy High
- Early Detection Accuracy High sensitivity and specificity
Who each tool is positioned for — primary audience first.
How you can reach support — email, live chat, phone, community, docs.
- Documentation primary
- Email primary
How each tool is classified in the Volvenix catalog.
These vocabulary domains are managed in our catalog but not yet exposed at the tool level. We're tracking them for future expansion of this comparison.
- Encryption Types — AES-256, ChaCha20, RSA-2048, and similar at-rest/in-transit cipher families.
- Encryption Contexts — where encryption is applied (data at rest, in transit, end-to-end).
- Plan-tier Model Mapping — which AI models are available on which pricing tier (currently only the model list is tracked, not the per-plan availability).
No screenshots uploaded yet.
- What is this tool?
- Isomorphic Labs uses AI to predict protein structures from sequences to aid drug discovery.
- How much does it cost?
- It offers a freemium model with limited public pricing details.
- Does it have a free plan?
- Yes, a free plan is available for basic access.
- What integrations does it support?
- No public integrations or APIs are currently documented.
- Who is it best for?
- Researchers and biotech teams focused on molecular modeling and precision medicine.
- What is this tool?
- Freenome is a platform that detects early-stage cancer from blood samples using AI-driven genomic and proteomic analysis.
- How much does it cost?
- Freenome offers a freemium model with limited public pricing details, primarily targeting clinical and research customers.
- Does it have a free plan?
- Yes, Freenome provides a free plan with basic access for research or evaluation purposes.
- What integrations does it support?
- Freenome does not publicly document integrations or APIs at this time.
- Who is it best for?
- It is best suited for healthcare professionals and researchers focused on early cancer detection and precision medicine.
| Info | Isomorphic Labs | Freenome |
|---|---|---|
| Pricing | Freemium | Freemium |
| Category | Synthetic Biology, BioAI & Genomics | Synthetic Biology, BioAI & Genomics |
| Deployment | Cloud | Cloud |
| Learning Curve | Advanced | Advanced |
| Free Plan | ✓ | ✓ |
| AI Agent | ✗ | ✗ |
| Autonomy | Assistant | Assistant |
| Risk Tier | Low | Medium |
BioNTech InstaDeep
Fabric Genomics
DeepMind AlphaFoldⓘ How Volvenix scores work
Scores are computed by Volvenix — not supplied by the vendors, and not third-party benchmark results. Each 0–10 dimension (Overall, Features, Usability, Support, Pricing) is a directional estimate aggregated from catalog signals — editorial cataloguing, content depth, engagement, and provider-reputation indicators — so treat them as a starting point, not a lab result.
Confidence reflects how complete the underlying data is for both tools; lower confidence means fewer signals were available, not a worse tool. We never accept payment for rankings or scores. More about how Volvenix works →